Brief: China Shineway Pharmaceutical Group Expects HY Profit Attributable To Increase By About 40%
31/07/2018 11:24
July 31 (Reuters) - China Shineway Pharmaceutical Group Ltd
2877.HK :
* HY PROFIT ATTRIBUTABLE EXPECTED TO INCREASE BY
APPROXIMATELY 40%
* EXPECTED RESULT DUE TO INCREASED AVERAGE SELLING PRICE AND
SALES
VOLUME OF GROUP'S PRODUCTS
Source text for Eikon: ID:nHKS8BhsNY
Further company coverage: 2877.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Shineway Pharmaceutical
See all newsBrief: China Shineway Pharmaceutical Posts Q1 Turnover Of RMB624 MLN
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln